Procalcitonin (PCT) is a protein that consists of 116 amino acids and is the peptide precursor
of calcitonin. Calcitonin is initially biosynthesized as PCT, which, under normal conditions, is …

Background Procalcitonin (PCT)-guided antibiotic discontinuation appears to decrease
antibiotic use in critically ill patients, but its impact on survival remains less certain. Methods …

Background Procalcitonin (PCT)-guided antibiotic stewardship (ABS) has been shown to
reduce antibiotics (ABxs), with lower side-effects and an improvement in clinical outcomes …

Sepsis is a clinical syndrome encompassing physiologic and biological abnormalities
caused by a dysregulated host response to infection. Sepsis progression into septic shock is …

Background Appropriate antibiotic (AB) therapy remains a challenge in the intensive care
unit (ICU). Procalcitonin (PCT)-guided AB stewardship could help optimize AB treatment and …

Procalcitonin (PCT) is useful for differentiating between viral and bacterial infections and for
reducing the unnecessary use of antibiotics. As the rise of antimicrobial resistance reaches …

This review aims to summarize current progress in the management of critically ill, using
biomarkers as guidance for antimicrobial treatment with a focus on antimicrobial …

Biomarkers to guide antibiotic treatment decisions have been proposed as an effective way
to enhancing a more appropriate use of antibiotics. As a biomarker, procalcitonin (PCT) has …

Introduction: Although evidence indicates that use of procalcitonin to guide antibiotic
decisions for the treatment of acute respiratory infections (ARI) decreases antibiotic …

Accurately identifying viruses from bacteria determine the therapy and outcome of patients
suffering from pneumonia. This study focuses on exploring the capability of machine …